Average Co-Inventor Count = 4.0

ph-index = 8

Forward Citations = 183(Granted Patents)

Company Filing History:

Ptc Therapeutics, Inc.

6. 1 out of 832,680

Other

patents

where one patent can have more than one assignee

Years Active: 2000-2011

Loading Chart...

15 patents (USPTO):Sort by Forward Citations

Abstract keywords

1. 7968567 - Compounds for the modulation of PPARγ activity (2011-06-28),

2. 7960408 - Quinolinyl and benzothiazolyl modulators (2011-06-14),

3. 7763656 - Use of Acetylamino benzoic acid compounds for nonsense suppression and the treatment of disease (2010-07-27),

4. 7626033 - Compounds for the modulation of PPARγ activity (2009-12-01),

5. 7601841 - Quinolinyl and benzothiazolyl modulators (2009-10-13),

6. 7439242 - PPARγ modulators (2008-10-21),

7. 7247741 - Acetylamino benzoic acid compounds and their use for nonsense suppression and the treatment of disease (2007-07-24),

8. 7244727 - Fused bicyclic nitrogen-containing heterocycles (2007-07-17),

9. 7041691 - Compounds for the modulation of PPARγ activity (2006-05-09),

10. 6770648 - Compounds for the modulation of PPAR&ggr; activity (2004-08-03),

11. 6630513 - Arylsulfonanilide derivates (2003-10-07),

12. 6620827 - PPAR&ggr; modulators (2003-09-16),

13. 6583157 - Quinolinyl and benzothiazolyl modulators (2003-06-24),

14. 6200995 - PPAR-&ggr; modulators (2001-03-13),

15. 6153585 - Arylsulfonanilide derivatives (2000-11-28),

Title: The Innovative Contributions of Steven Marc Rubenstein

Introduction

Steven Marc Rubenstein is a notable inventor based in Pacifica, CA (US). He has made significant contributions to the field of pharmaceuticals, particularly in the modulation of PPARγ activity. With a total of 15 patents to his name, Rubenstein's work has the potential to impact the treatment of various metabolic conditions.

Latest Patents

Rubenstein's latest patents include innovative compounds for the modulation of PPARγ activity. These modulators are useful in pharmaceutical compositions and methods for treating conditions such as type II diabetes and obesity. Another significant patent involves quinolinyl and benzothiazolyl modulators, which provide compounds, compositions, and methods that are beneficial in treating or preventing conditions mediated by PPARγ. Specifically, these compounds modulate the function of PPARγ and are particularly useful in addressing diabetes, obesity, hypercholesterolemia, rheumatoid arthritis, and atherosclerosis.

Career Highlights

Throughout his career, Rubenstein has worked with prominent companies in the pharmaceutical industry, including Amgen Inc. and Tularik Limited. His experience in these organizations has allowed him to develop and refine his innovative ideas, contributing to advancements in medical treatments.

Collaborations

Rubenstein has collaborated with notable professionals in his field, including Lawrence R McGee and Jonathan B Houze. These collaborations have further enriched his research and development efforts.

Conclusion

Steven Marc Rubenstein's contributions to the field of pharmaceuticals through his innovative patents and collaborations highlight his role as a significant inventor. His work continues to pave the way for advancements in the treatment of critical health conditions.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.